New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
about
Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in AsiaTranscriptomic profile of host response in Japanese encephalitis virus infectionVaccines for preventing Japanese encephalitisMolecular characterization of Japanese encephalitis virus strains prevalent in Chinese swine herdsShell Vial Culture assay for the rapid diagnosis of Japanese encephalitis, West Nile and Dengue-2 viral encephalitis.Estimated global incidence of Japanese encephalitis: a systematic reviewProduct review on the JE vaccine IXIAROJapanese encephalitis: the virus and vaccinesEstimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong regionNuclear localization of Japanese encephalitis virus core protein enhances viral replication.A hospital-based surveillance for Japanese encephalitis in Bali, IndonesiaOrigin and Evolution of Japanese Encephalitis Virus in Southeast AsiaDevelopment and Application of a Reverse Genetics System for Japanese Encephalitis VirusStable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit VaccineProcessing of Capsid Protein by Cathepsin L Plays a Crucial Role in Replication of Japanese Encephalitis Virus in Neural and Macrophage CellsDoes Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells?Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In VivoA Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in MicePast, Present, and Future of Japanese EncephalitisEvidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillanceHospital-Based Surveillance for Japanese Encephalitis at Four Sites in Bangladesh, 2003-2005Etiological Spectrum of Clinically Diagnosed Japanese Encephalitis Cases Reported in Guizhou Province, China, in 2006Japanese encephalitis: Challenges and intervention opportunities in Nepal.Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus.Risk factors for Japanese encephalitis: a case-control study.The neglected arboviral infections in mainland China.Production of Japanese Encephalitis Virus Antigens in Plants Using Bamboo Mosaic Virus-Based VectorPersistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV ImmunizationJapanese encephalitis in travelers from non-endemic countries, 1973-2008Pediatricians' perceptions of vaccine effectiveness and safety are significant predictors of vaccine administration in India.Disability after encephalitis: development and validation of a new outcome score.Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity.Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam.Molecular detection and genotyping of Japanese encephalitis virus in mosquitoes during a 2010 outbreak in the Republic of Korea.Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foalsIdentification of a mutated BHK-21 cell line that became less susceptible to Japanese encephalitis virus infection.Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes.Japanese encephalitis vaccine in travelers.TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection
P2860
Q21144497-57305A8D-67B3-4064-A3E5-E0E78A0B3013Q21245096-2DC01D9A-877F-40FF-83EC-998296B11E34Q24243819-AF522ACC-5BE8-4B57-BD70-696A7E6C460AQ24498635-995FB1B2-5C34-45A2-BE21-7FDC070CBF48Q25255383-807EA52F-3F85-4079-90F8-C9AA742537DFQ26829180-20E3CF3C-3116-42A0-AC70-258C71A08023Q26866171-85953B13-B6EC-43F2-BB04-E0717514DD30Q27010434-A1103C10-BCED-43B1-9CA6-1273E5D81CF9Q27024627-F8C527A1-231F-4C77-9AB1-7263735AE683Q27469457-8B11271D-E0DB-4376-A628-F470CE2D8C9DQ27473264-3B574B4E-CC34-458B-962E-D31EED9CFBD6Q27473338-EE63A5BD-792D-4314-BCD1-BD8C62E34DC9Q27473506-2DAA23E7-102A-459B-8D40-804C14224EA6Q27477712-B98EF574-AF3B-4191-BE5F-6079D5BC2195Q27481023-AA3D844C-DA53-48AD-91C5-CEFEED9CFB69Q27481648-5DFA9F4B-BF48-4282-9ECB-7B483BA7882CQ27486404-BE1FA5CE-63F4-4D72-AB61-EDA9D30DDF7FQ27486779-4280D7A5-909E-41C3-810F-F3102CD3618FQ27488252-6716B5F5-91BC-4C6E-9720-14AF833F6E57Q27490819-864F1E7D-43FC-4E45-98AA-27FCF491EADDQ27490858-84805EF9-3B15-4603-A160-5069C7C7DC3CQ27491328-B0BD0F75-EDC0-478B-AD77-A99BB31B7B63Q31068975-0651ECCF-9DF6-451A-84B4-6FAC910AA5EDQ33288231-F06963B3-134B-49B8-96B2-EE4197B1BD64Q33527165-8EFBDB05-6C9A-41D7-BA1E-981EB27C7509Q33570581-C56A91DA-1163-4C34-8D37-84804E1AB7E3Q33627913-13EA3FF1-66A2-45A9-9EFE-6416489F6AEAQ33712740-62451318-18F3-45D7-8A3A-CC00A34BEC4DQ33817509-F0E27F20-C766-4F84-B16F-7F2D7C08C38FQ33910984-E8AAFE9F-FF63-4EBA-A260-D7A89D67436EQ34015604-2BC4875D-2FE4-4CE9-9CC1-FDD88293BE27Q34261807-D53E8F69-14D4-423C-945A-97E59E51A0DAQ34526252-65138A1B-341E-44C3-BA09-D0D23427222AQ34580021-C877A6F7-60BD-4177-99F7-64E93D46F7A3Q34694967-35FD0629-5C2B-4B6F-9032-DC5E19A78E6EQ34720701-4C57520D-0BEE-4E44-B603-2651BC4757EAQ34722619-403048A1-E962-431C-8B98-A62013756466Q34742978-2387F632-69F0-4D1B-8177-BFD3607C379FQ34787426-6ED3DCA0-29F5-4E27-8DE1-859B4033187FQ34937936-78F51906-D735-4E21-998D-95CA03752BE0
P2860
New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@en
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@nl
type
label
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@en
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@nl
prefLabel
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@en
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@nl
P1433
P1476
New initiatives for the contro ...... Thailand, 13-15 October 1998.
@en
P2093
P356
10.1016/S0264-410X(00)00037-2
P407
P478
18 Suppl 2
P577
2000-05-01T00:00:00Z